Efficacy and safety of different doses and retreatment of rituximab: A randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)) (Annals of the Rheumatic Diseases (2010) 69, (1629-1635))

P. Emery, A. Deodhar, W. F. Rigby

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalAnnals of the rheumatic diseases
Volume70
Issue number8
DOIs
StatePublished - Aug 1 2011

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this